1,2-dimyristoylphosphatidylethanolamine has been researched along with 3-tyr-octreotide in 1 studies
Studies (1,2-dimyristoylphosphatidylethanolamine) | Trials (1,2-dimyristoylphosphatidylethanolamine) | Recent Studies (post-2010) (1,2-dimyristoylphosphatidylethanolamine) | Studies (3-tyr-octreotide) | Trials (3-tyr-octreotide) | Recent Studies (post-2010) (3-tyr-octreotide) |
---|---|---|---|---|---|
216 | 0 | 59 | 95 | 2 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreae, F; Decristoforo, C; Helbok, A; Prassl, R; Radolf, T; Rangger, C; Saba-Lepek, M; Thurner, G; von Guggenberg, E | 1 |
1 other study(ies) available for 1,2-dimyristoylphosphatidylethanolamine and 3-tyr-octreotide
Article | Year |
---|---|
Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Inhibitory Concentration 50; Iridium Radioisotopes; Liposomes; Mice; Mice, Nude; Micelles; Nanoparticles; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Inbred Lew; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2012 |